Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

Check price, lot and GMP of the last issue of 2025 Modern Diagnostic SME IPO is going to be a public the bidding process of ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

AI chatbot achieves high accuracy in performing clinical patient diagnostic interviews for common mental health disorders.

In parallel with the tendered offer, PathoCare Holdings announced that-based on stronger-than-expected institutional interest and market demand-the Company is increasing the size of its contemplated ...

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

The meeting focused on public health system strengthening, patient-centric care, regulatory oversight, diagnostic services, ...

Learn more about whether Charles River Laboratories International, Inc. or Thermo Fisher Scientific Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

Learn more about whether Agilent Technologies, Inc. or Charles River Laboratories International, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...